Zhao Qing, Xu Jinsen
Key Laboratory of the Ministry of Education for Cell Biology and Tumor Cell Engineering, School of Life Sciences, Xiamen University, Xiamen 361005, China.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2005 Feb;22(1):181-4.
The technique of embryonic stem cell test (EST) has been developed and used in vitro to screen new medicines and other chemicals. According to toxicity, such medicines and chemicals can be classified as: non-toxic, weak toxic and/or strong toxic. EST shows merits such as no requirement of the sacrifice of pregnant animals, no side-effects on human or animals for candidate medicines and chemicals, higher sensitivity of embryonic stem cells when compared with the sensitivity of ordinary tissues of adult samples in toxicologic researches, higher accuracy when combined with computing techniques, and possible quantitation based on techniques of molecular biology. Advances in utility of EST technique were reviewed and the prospect of technique was also discussed in this paper.
胚胎干细胞试验(EST)技术已得到发展并用于体外筛选新药和其他化学品。根据毒性,此类药物和化学品可分为:无毒、低毒和/或高毒。EST具有诸多优点,如无需牺牲怀孕动物,对候选药物和化学品对人或动物无副作用,在毒理学研究中胚胎干细胞比成年样本普通组织的敏感性更高,与计算技术结合时准确性更高,以及基于分子生物学技术可能实现定量分析。本文综述了EST技术应用方面的进展,并对该技术的前景进行了探讨。